At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and learning & development are headed. No scripts, no slides — just honest takes from the people doing the work.
In this episode, you'll hear from six pharma L&D leaders on how AI is changing their roles, what they're doing differently at national sales meetings, the adoption challenges they're navigating, and why L&D may be the most strategically important function in any AI rollout.
Timestamps:
1:43 — Andrea Penn, Senior Director of Field Training & Customer Training, Autolus Therapeutics
7:38 — Sarah Barrett, Associate Director of Medical Affairs Training, Alnylam Pharmaceuticals
13:10 — Brian McCann, Dupixent Market Access Training, Regeneron
18:49 — Nicole Payne, Director of Global Commercial L&D, BioMarin
Podden och tillhörande omslagsbild på den här sidan tillhör
Jonathan Kaskey. Innehållet i podden är skapat av Jonathan Kaskey och inte av,
eller tillsammans med, Poddtoppen.